-- Bary G. Bailey. Mr. Bailey served as Executive Vice President and
Chief Financial Officer of Valeant Pharmaceuticals International
(formerly ICN Pharmaceuticals, Inc.) from December 2002 to May 2007 and
as Executive Vice President, Strategy and Technology, of PacifiCare
Health Systems, Inc. from July 2000 to December 2002.
-- Jay B. Hunt. Mr. Hunt has served as a Principal of The Development
Group since 1993, served as Executive Vice President of FM Productions
from 1988 to 1990, as Chief Executive Officer of FN Realty Services,
Inc. from 1983 to 1987 and is currently the non-executive Chairman of
-- Anthony H. Wild, Ph.D. Dr. Wild has served as a general partner of
Bows Pharmaceuticals AG since October 2006, served as the Chairman and
Chief Executive Officer of MedPointe Pharmaceuticals, Inc. from
September 2001 to April 2006, as President of the Warner-Lambert
Company's Global Pharmaceutical Sector from 1995 to 2000 and is
currently a member of the Board of Directors of Millennium
In addition, Roche notified Ventana of its intent to nominate Philip R.
Lochner, Jr. and/or David A. Dodd as additional or substitute nominees for
election to Ventana's Board of Directors if one or more of the nominees is
unable to serve:
-- Philip R. Lochner, Jr. Mr. Lochner served as Senior Vice President and
Chief Administrative Officer of Time Warner Inc. from 1991 to 1998, as
a Commissioner of the Securities and Exchange Commission from March
1990 to July 1991 and is currently a member of the Board of Directors
of Apria Healthcare Group Inc., Clarcor Inc., Crane Co., CMS Energy
Corporation and Monster Worldwide Inc.
-- David A. Dodd. Mr. Dodd has served as Chairma
Copyright©2007 PR Newswire.
All rights reserved